4-羟基苯基丙酮

4-羟基苯基丙酮
	IUPAC名; 1-(4-Hydroxyphenyl)propan-2-one
别名	p-Hydroxyphenylacetone; para-Hydroxyphenylacetone
识别
CAS号	770-39-8
PubChem	7019274
ChemSpider	5382241
SMILES	CC(=O)CC1=CC=C(C=C1)O;
InChI	1S/C9H10O2/c1-7(10)6-8-2-4-9(11)5-3-8/h2-5,11H,6H2,1H3;
InChIKey	VWMVAQHMFFZQGD-UHFFFAOYSA-N
性质
化学式	C9H10O2
摩尔质量	150.17 g·mol−1
	若非注明，所有数据均出自一般条件（25 ℃，100 kPa）下。

4-羟基苯基丙酮（）是苯基丙酮（苯丙胺在人体中的不活泼代谢产物）的羟基类似物。[1][2]当它作为苯丙胺的代谢产物出现时，它通常是由不活泼的代谢物苯基丙酮中直接产生。[1][3]

苯丙胺的代謝途徑[sources 1]

4-Hydroxyamphetamine

4-Hydroxynorephedrine

Para-
Hydroxylation

Beta-
Hydroxylation

Oxidative
Deamination

Oxidation

Glycine
Conjugation

人体中，4-羟基苯基丙酮是苯丙胺和苯基丙酮的代谢产物。

参注

[3][4][5][6][7][8][9][10]

参考资料

Santagati NA, Ferrara G, Marrazzo A, Ronsisvalle G. . J. Pharm. Biomed. Anal. September 2002, 30 (2): 247–55. PMID 12191709. doi:10.1016/S0731-7085(02)00330-8.
. NCBI. PubChem Compound. [2013-10-25]. （原始内容存档于2014-01-08）.
(PDF). United States Food and Drug Administration. Shire US Inc: 12–13. December 2013 [30 December 2013]. （原始内容存档 (PDF)于2018-07-18）.
Glennon RA. . Lemke TL, Williams DA, Roche VF, Zito W (编). 7th. Philadelphia, USA: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2013: 646–648 [2018-06-20]. ISBN 9781609133450. （原始内容存档于2020-07-26）.
Taylor KB. (PDF). J. Biol. Chem. January 1974, 249 (2): 454–458 [6 November 2014]. PMID 4809526. （原始内容存档 (PDF)于2019-04-04）.
Krueger SK, Williams DE. . Pharmacol. Ther. June 2005, 106 (3): 357–387. PMC 1828602. PMID 15922018. doi:10.1016/j.pharmthera.2005.01.001.
Table 5: N-containing drugs and xenobiotics oxygenated by FMO 页面存档备份，存于
Cashman JR, Xiong YN, Xu L, Janowsky A. . J. Pharmacol. Exp. Ther. March 1999, 288 (3): 1251–1260. PMID 10027866.
Santagati NA, Ferrara G, Marrazzo A, Ronsisvalle G. . J. Pharm. Biomed. Anal. September 2002, 30 (2): 247–255. PMID 12191709. doi:10.1016/S0731-7085(02)00330-8.
Sjoerdsma A, von Studnitz W. . Br. J. Pharmacol. Chemother. April 1963, 20: 278–284. PMC 1703637. PMID 13977820. doi:10.1111/j.1476-5381.1963.tb01467.x.
Badenhorst CP, van der Sluis R, Erasmus E, van Dijk AA. . Expert Opin. Drug Metab. Toxicol. September 2013, 9 (9): 1139–1153. PMID 23650932. doi:10.1517/17425255.2013.796929.

外部链接

MeSH（醫學主題詞）上面的4-hydroxyphenylacetone（美式英语）

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[amphetamine_metabolism-11] [3][4][5][6][7][8][9][10]

[pmid12191709-1] Santagati NA, Ferrara G, Marrazzo A, Ronsisvalle G. . J. Pharm. Biomed. Anal. September 2002, 30 (2): 247–55. PMID 12191709. doi:10.1016/S0731-7085(02)00330-8.

[2] . NCBI. PubChem Compound. [2013-10-25]. （原始内容存档于2014-01-08）.

[FDA_Pharmacokinetics-3] (PDF). United States Food and Drug Administration. Shire US Inc: 12–13. December 2013 [30 December 2013]. （原始内容存档 (PDF)于2018-07-18）.

[Substituted_amphetamines,_FMO,_and_DBH-4] Glennon RA. . Lemke TL, Williams DA, Roche VF, Zito W (编). 7th. Philadelphia, USA: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2013: 646–648 [2018-06-20]. ISBN 9781609133450. （原始内容存档于2020-07-26）.

[DBH_amph_primary-5] Taylor KB. (PDF). J. Biol. Chem. January 1974, 249 (2): 454–458 [6 November 2014]. PMID 4809526. （原始内容存档 (PDF)于2019-04-04）.

[FMO-6] Krueger SK, Williams DE. . Pharmacol. Ther. June 2005, 106 (3): 357–387. PMC 1828602. PMID 15922018. doi:10.1016/j.pharmthera.2005.01.001.
Table 5: N-containing drugs and xenobiotics oxygenated by FMO 页面存档备份，存于

[FMO3-Primary-7] Cashman JR, Xiong YN, Xu L, Janowsky A. . J. Pharmacol. Exp. Ther. March 1999, 288 (3): 1251–1260. PMID 10027866.

[Metabolites-8] Santagati NA, Ferrara G, Marrazzo A, Ronsisvalle G. . J. Pharm. Biomed. Anal. September 2002, 30 (2): 247–255. PMID 12191709. doi:10.1016/S0731-7085(02)00330-8.

[pmid13977820-9] Sjoerdsma A, von Studnitz W. . Br. J. Pharmacol. Chemother. April 1963, 20: 278–284. PMC 1703637. PMID 13977820. doi:10.1111/j.1476-5381.1963.tb01467.x.

[Glycine_conjugation_review-10] Badenhorst CP, van der Sluis R, Erasmus E, van Dijk AA. . Expert Opin. Drug Metab. Toxicol. September 2013, 9 (9): 1139–1153. PMID 23650932. doi:10.1517/17425255.2013.796929.